When a Drug Program Expects Multiple Global Dx Partners: Considerations for Master CDx Agreements
9:50 am - Thursday 8th October 2026
- What are the downstream commercial considerations for a co-developing and co-labeling projects?
- How do parties manage their respective Intellectual Property portfolios when multiple global partners are likely?
- What are the baseline and optional additional commercial supplements when negotiating Master CDx Agreements?
